US 7851631
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61PA61P1/06A61P1/12
Quick answer
US patent 7851631 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/06, A61P1/12, A61P11/00, A61P11/02